Home Page
01:11:36 EDT Thu 23 Oct 2014
Enter Symbol
or Name
USA
CA



MVC CAPITAL INC
Symbol U : MVC
Recent Sedar Documents

MVC Capital Announces Sale of Summit Research Labs

2013-02-13 08:45 ET - News Release

Company to Record an Approximate Gain of $47 Million From Sale of Portfolio Company

MVC to Retain Summit's Custom Spray Drying Business

PURCHASE, N.Y., Feb. 13, 2013 (GLOBE NEWSWIRE) -- MVC Capital, Inc. (NYSE:MVC) (the "Company"), a publicly traded business development company that makes private debt and equity investments, announced today the signing of a definitive agreement to sell one of its portfolio companies, Summit Research Labs ("Summit"), a specialty chemical company that manufactures and markets antiperspirant actives globally, to an affiliate of One Rock Capital Partners, LLC, subject to regulatory approvals and the satisfaction of other customary closing conditions, including an escrow.

Prior to the completion of the transaction, MVC and other existing Summit shareholders will purchase Summit Custom Spray Drying ("SCSD") from Summit. These proceeds are expected to be returned to Summit's shareholders upon completion of the Summit sale to One Rock. SCSD provides custom spray drying products to the food, pharmaceutical, nutraceutical, flavor and fragrance industries. SCSD will operate as a stand-alone business following the closing of the Summit sale. 

Assuming full realization of the closing conditions and escrow and the sale of SCSD, MVC Capital would receive gross proceeds from its equity investment of approximately $63 million, that results in an estimated gross IRR of 31% since August 2006 (the time of the original investment). The gross IRR includes all fees and distributions received from its equity position in Summit over the life of the investment. The transaction is expected to close prior to March 31, 2013. 

As part of the sale, MVC will provide Summit with a $22 million second lien loan. 

"We are pleased to have reached an agreement to monetize our investment in Summit, expected to result in a realized gain of approximately $47 million[1]. This gain is in addition to the $12 million special dividend MVC received from Summit in 2012, adding to the overall return of this investment and highlighting our ability to build shareholder value," said Michael Tokarz, Chairman and Portfolio Manager of MVC. "MVC's management will look to redeploy the proceeds from the sale of Summit with a focus on building shareholder value."  

"We have enjoyed working with Summit's highly skilled management team to build the company into a leading global manufacturer of antiperspirant actives, and we look forward to continuing to support the success of the team as a lender under One Rock ownership," said Shivani Khurana, Director of Summit and Managing Director of TTGA, investment adviser to MVC Capital, Inc.

Lazard Middle Market served as financial advisor to Summit on its sale to an affiliate of One Rock.

MVC-G

About MVC Capital, Inc.

MVC is a business development company traded on the New York Stock Exchange that provides long-term debt and equity investment capital to fund growth, acquisitions and recapitalizations of companies in a variety of industries. For additional information about MVC, please visit the MVC's website at www.mvccapital.com.

Forward-Looking Statements

The information contained in this press release contains forward-looking statements. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. Certain factors could cause actual results and conditions to differ materially from those projected in these forward-looking statements, and these factors are enumerated in the company's periodic filings with the Securities and Exchange Commission.

[1] The anticipated $47 million gain assumes the full receipt of all escrow proceeds. 

CONTACT: Investor Relations
         Jackie Rothchild
         MVC Capital
         914-510-9400
         or
         Jeffrey Goldberger / Garth Russell
         KCSA Strategic Communications
         212-896-1249 / 212-896-1250
         
         Media Inquiries
         Nathaniel Garnick, Sard Verbinnen & Co.
         212-687-8080

© 2014 Canjex Publishing Ltd. All rights reserved.